Thrombectomy in ST Elevation Myocardial Infarction, an Individual Patient Meta-analysis
- Conditions
- Acute Coronary SyndromesMyocardial Infarction
- Interventions
- Device: Manual Aspiration Thrombectomy
- Registration Number
- NCT02552407
- Lead Sponsor
- Population Health Research Institute
- Brief Summary
During primary percutaneous coronary intervention, distal embolization of thrombus and impaired microvascular perfusion has been associated with an increased mortality. Thrombectomy devices during primary percutaneous coronary intervention may prevent distal embolization by reducing thrombus burden and thus improve microvascular perfusion and reduce mortality.
- Detailed Description
An individual patient meta-analysis of large randomized controlled trials comparing manual thrombectomy versus percutaneous coronary intervention alone in patients with ST elevation myocardial infarction will provide significantly more power to detect differences in mortality as well as important but rare events such as stroke and to assess benefits in pre-defined subgroups.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 18000
- Randomized controlled trials comparing manual thrombectomy vs. percutaneous coronary intervention alone in patients with ST elevation myocardial infarction published between January 1980 and April 2015.
- Large trials randomizing more than 1000 patients.
- Trials must have had at least 30 day follow up.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Manual Aspiration Thrombectomy with PCI Manual Aspiration Thrombectomy Subjects from the randomized controlled trials to be included in this meta-analysis will have been randomly allocated to Manual Aspiration Thrombectomy followed by percutaneous coronary intervention (PCI).
- Primary Outcome Measures
Name Time Method Occurrence of Cardiovascular death up to 30 days time to event analysis
- Secondary Outcome Measures
Name Time Method Occurrence of Cardiovascular death up to 180 days time to event analysis